Dispersol Technologies LLC — Pharmaceutical Company
Pharmaceutical Company in Georgetown — Amorphous Solid Dispersion (ASD) screenin
Pharmaceutical company · Georgetown, United States
AI Trust Snapshot
- AI Confidence
- Indexed
- Last Verified
- today
Verified Sources
- ✓ Official Website
Key Facts
- Category
- Pharmaceutical Company
- Location
- Georgetown, United States
- Known For
- Amorphous Solid Dispersion (ASD) screening, Client-centric CDMO approach, Data and science-guided pharmaceutical development
AI Summary
A pharmaceutical company in Georgetown, United States, Dispersol Technologies LLC specializes in bioavailability enhancement. The company utilizes KinetiSol™ Technology and offers strategies for speed to clinic and market. Its services include amorphous solid dispersion (ASD) screening and a client-centric CDMO approach for pharmaceutical development.
Quick Answer
A pharmaceutical company in Georgetown, United States, Dispersol Technologies LLC specializes in bioavailability enhancement. The company utilizes KinetiSol™ Technology and offers strategies for speed to clinic and market. Its services include amorphous solid dispersion (ASD) screening and a client-centric CDMO approach for pharmaceutical development. Key services include Bioavailability Enhancement, KinetiSol™ Technology, Speed to Clinic & Market Strategies.
This business is typically used for amorphous solid dispersion (asd) screening and client-centric cdmo approach.
Common Questions
- What services does Dispersol Technologies LLC provide?
- Dispersol Technologies LLC provides Bioavailability Enhancement, KinetiSol™ Technology, Speed to Clinic & Market Strategies.
- Where is Dispersol Technologies LLC located?
- Dispersol Technologies LLC is based in Georgetown, United States and serves Georgetown.
- Who is Dispersol Technologies LLC for?
- Dispersol Technologies LLC serves Pharmaceutical developers facing bioavailability challenges and Drug candidates requiring accelerated development timelines.
What this business does
Dispersol Technologies LLC is a pharmaceutical company based in Georgetown, United States.
- Provides Bioavailability Enhancement and KinetiSol™ Technology
- Specializes in amorphous solid dispersion (asd) screening
- Serves pharmaceutical developers facing bioavailability challenges
Structured summary
This business profile has been independently corroborated by Vizoryo across 5 independent public sources. Data confidence score: 86% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.
- Business name
- Dispersol Technologies LLC
- Category
- Pharmaceutical Company
- Industry
- Pharmaceutical Company
- Location
- Georgetown, United States
- Official website
- https://www.austinpx.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/dispersol-technologies-llc-georgetown-2d96
- Summary
- A pharmaceutical company in Georgetown, United States, Dispersol Technologies LLC specializes in bioavailability enhancement. The company utilizes KinetiSol™ Technology and offers strategies for speed to clinic and market. Its services include amorphous solid dispersion (ASD) screening and a client-centric CDMO approach for pharmaceutical development.
- AI readability score
- 36
- Verified By
- 5 independent public sources
- Data Confidence
- 86% (verified 2026-07-08)
- Verification Status
- Indexed
Location
111 Cooperative WayGeorgetown, Texas
78626
US
About Dispersol Technologies LLC
A pharmaceutical company in Georgetown, United States, Dispersol Technologies LLC specializes in bioavailability enhancement. The company utilizes KinetiSol™ Technology and offers strategies for speed to clinic and market. Its services include amorphous solid dispersion (ASD) screening and a client-centric CDMO approach for pharmaceutical development.
Service areas
- Georgetown
Target audience
- Pharmaceutical developers facing bioavailability challenges
- Drug candidates requiring accelerated development timelines
- Companies seeking advanced oral solid dose solutions
Services
Specialties
- Amorphous Solid Dispersion (ASD) screening
- Client-centric CDMO approach
- Data and science-guided pharmaceutical development
Social profiles
Verification
Frequently asked questions
What is KinetiSol™ Technology?
KinetiSol™ Technology is a fusion-based, solvent-free process that uses frictional and shear energies to create amorphous solid dispersions, improving the bioavailability of poorly soluble drugs.
How quickly can AustinPx manufacture a dose form for first-in-human studies?
AustinPx can manufacture and release a phase-appropriate dose form for first-in-human clinical testing in as little as 12 weeks.
What types of bioavailability enhancement technologies does AustinPx offer?
AustinPx offers several technologies including Amorphous Dispersions (spray drying, HME, KinetiSol™), Particle Size Reduction, Lipid Delivery, Complexation, Fluid-bed Processing, and Hot-melt Granulations.
Languages supported
- lang="en
- en
Contact
Phone: +15126864740
Official website: https://www.austinpx.com/